Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11760809 Human monoclonal antibodies to ganglioside GD2

Patent 11760809 was granted and assigned to BioNTech SE on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
BioNTech SE
Date Filed
December 22, 2020
Date of Patent
September 19, 2023
Patent Applicant
‌
BioNTech SE
Patent Application Number
17131713
Patent Citations
‌
US Patent 9856324 Human monoclonal antibodies to ganglioside GD2
‌
US Patent 7981695 Diagnostic methods using plasmon resonant particles
‌
US Patent 8039273 β-glucuronide-linker drug conjugates
‌
US Patent 8142784 Antibody-drug conjugates and methods
‌
US Patent 8216581 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof
‌
US Patent 10906988 Human monoclonal antibodies to ganglioside GD2
Patent Inventor Names
Wolfgang Scholz
Ritsuko Sawada
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11760809
Patent Primary Examiner
‌
Lei Yao
CPC Code
‌
C07K 2317/33
‌
C07K 2317/56
‌
A61K 2039/505
‌
A61K 45/06
‌
A61K 39/39558
‌
C07K 2317/565
‌
C07K 2317/21

Find more entities like US Patent 11760809 Human monoclonal antibodies to ganglioside GD2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.